Anti-PTPRK/ R-PTP-kappa monoclonal antibody

Anti-PTPRK/ R-PTP-kappa antibody for FACS & in-vivo assay

Target products collectionGo to PTPRK/PTPRK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1431-Ab-1/ GM-Tg-hg-MP1431-Ab-2Anti-Human PTPRK monoclonal antibodyHuman
GM-Tg-rg-MP1431-Ab-1/ GM-Tg-rg-MP1431-Ab-2Anti-Rat PTPRK monoclonal antibodyRat
GM-Tg-mg-MP1431-Ab-1/ GM-Tg-mg-MP1431-Ab-2Anti-Mouse PTPRK monoclonal antibodyMouse
GM-Tg-cynog-MP1431-Ab-1/ GM-Tg-cynog-MP1431-Ab-2Anti-Cynomolgus/ Rhesus macaque PTPRK monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1431-Ab-1/ GM-Tg-felg-MP1431-Ab-2Anti-Feline PTPRK monoclonal antibodyFeline
GM-Tg-cang-MP1431-Ab-1/ GM-Tg-cang-MP1431-Ab-2Anti-Canine PTPRK monoclonal antibodyCanine
GM-Tg-bovg-MP1431-Ab-1/ GM-Tg-bovg-MP1431-Ab-2Anti-Bovine PTPRK monoclonal antibodyBovine
GM-Tg-equg-MP1431-Ab-1/ GM-Tg-equg-MP1431-Ab-2Anti-Equine PTPRK monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1431-Ab-1/ GM-Tg-hg-MP1431-Ab-2; GM-Tg-rg-MP1431-Ab-1/ GM-Tg-rg-MP1431-Ab-2;
GM-Tg-mg-MP1431-Ab-1/ GM-Tg-mg-MP1431-Ab-2; GM-Tg-cynog-MP1431-Ab-1/ GM-Tg-cynog-MP1431-Ab-2;
GM-Tg-felg-MP1431-Ab-1/ GM-Tg-felg-MP1431-Ab-2; GM-Tg-cang-MP1431-Ab-1/ GM-Tg-cang-MP1431-Ab-2;
GM-Tg-bovg-MP1431-Ab-1/ GM-Tg-bovg-MP1431-Ab-2; GM-Tg-equg-MP1431-Ab-1/ GM-Tg-equg-MP1431-Ab-2
Products NameAnti-PTPRK monoclonal antibody
Formatmab
Target NamePTPRK
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PTPRK benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PTPRK/ R-PTP-kappa VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1431
    Target NamePTPRK
    Gene ID5796,19272,360302,711429,476290,101092366,509657,100073063
    Gene Symbol and SynonymsPTPk,PTPRK,R-PTP-kappa,Rptpk,RPTPkappa
    Uniprot AccessionQ15262
    Uniprot Entry NamePTPRK_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000152894
    Target ClassificationTumor-associated antigen (TAA)

    The target: PTPRK, gene name: PTPRK, also named as R-PTP-kappa. The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains a meprin-A5 antigen-PTP mu (MAM) domain, an Ig-like domain and four fibronectin type III-like repeats. This PTP was shown to mediate homophilic intercellular interaction, possibly through the interaction with beta- and gamma-catenin at adherens junctions. Expression of this gene was found to be stimulated by TGF-beta 1, which may be important for the inhibition of keratinocyte proliferation. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.